Paper10125
Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker.
Brown HC and 6 others. Clin Pharmacol Ther, 1976. Cited by 141 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker. Papers, record 10125. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10125
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Atenolol | Major topic |
| Propanolamines | Major topic |
| Administration, Oral | |
| Adrenergic beta-Antagonists | |
| Adult | |
| Biological Availability | |
| Depression, Chemical | |
| Drug Administration Schedule | |
| Half-Life | |
| Heart Rate | |
| Humans | |
| Injections, Intravenous | |
| Male | |
| Models, Biological | |
| Physical Exertion | |
| Time Factors |
Source PubMed
Cited by60
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 141 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,186,443 | A literature review of the pharmacokinetic profiles of 20 commonly prescribed antihypertensive medications for use in chemical adherence testing. | J Hypertens | 2026 | https://conductscience.org/library/papers/42186443 | PubMed |
| 40,853,187 | Application of Lactation Physiologically Based Pharmacokinetic Modeling to Predict Milk Exposure of Passively Diffused Drugs. | J Clin Pharmacol | 2025 | https://conductscience.org/library/papers/40853187 | PubMed |
| 38,540,438 | Pediatric Beta Blocker Therapy: A Comprehensive Review of Development and Genetic Variation to Guide Precision-Based Therapy in Children, Adolescents, and Young Adults. | Genes (Basel) | 2024 | https://conductscience.org/library/papers/38540438 | PubMed |
| 34,112,223 | Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup. | Crit Care | 2021 | https://conductscience.org/library/papers/34112223 | PubMed |
| 28,405,886 | Pharmacokinetic Variability of Drugs Used for Prophylactic Treatment of Migraine. | CNS Drugs | 2017 | https://conductscience.org/library/papers/28405886 | PubMed |
| 26,374,172 | Atenolol Renal Secretion Is Mediated by Human Organic Cation Transporter 2 and Multidrug and Toxin Extrusion Proteins. | Drug Metab Dispos | 2015 | https://conductscience.org/library/papers/26374172 | PubMed |
| 20,919,350 | Review of clinical pharmacology of atenolol. | Proc R Soc Med | 1977 | https://conductscience.org/library/papers/20919350 | PubMed |
| 20,795,842 | Atenolol exposure and risk for development of adverse metabolic effects: a pilot study. | Pharmacotherapy | 2010 | https://conductscience.org/library/papers/20795842 | PubMed |
| 20,645,106 | Cardiac vagal withdrawal and reactivation during repeated rest-exercise transitions. | Eur J Appl Physiol | 2010 | https://conductscience.org/library/papers/20645106 | PubMed |
| 18,794,726 | Beta-1-adrenoceptor genetic variants and ethnicity independently affect response to beta-blockade. | Pharmacogenet Genomics | 2008 | https://conductscience.org/library/papers/18794726 | PubMed |
| 10,091,273 | Exercise metabolism and beta-blocker therapy. An update. | Sports Med | 1999 | https://conductscience.org/library/papers/10091273 | PubMed |
| 7,461,026 | Pharmacokinetics of atenolol in relation to renal function. | Eur J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7461026 | PubMed |
| 7,418,712 | Pharmacokinetics of atenolol in hypertensive subjects with and without co-administration of chlorthalidone. | Eur J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/7418712 | PubMed |
| 7,378,254 | Pharmacokinetics of atenolol in patients with terminal renal failure and influence of haemodialysis. | Br J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/7378254 | PubMed |
| 7,371,709 | A single and multiple dose pharmacokinetic and pharmacodynamic comparison of conventional and slow-release metroprolol. | Eur J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/7371709 | PubMed |
| 7,356,891 | Comparison of the efficacy and pharmacokinetics of conventional propranolol and a long acting preparation of propranolol. | Br J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/7356891 | PubMed |
| 7,332,738 | Atenolol in the treatment of pregnancy-induced hypertension. | Br J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7332738 | PubMed |
| 7,308,277 | Relative activities of atenolol and metoprolol on the cardiovascular system of man. | Eur J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7308277 | PubMed |
| 7,272,165 | Comparison of the duration of effect of metoprolol and a sustained release formulation of metoprolol (betaloc-SA). | Br J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7272165 | PubMed |
| 7,176,462 | Interaction of metoprolol, propranolol and atenolol with concurrent administration of cimetidine. | Klin Wochenschr | 1982 | https://conductscience.org/library/papers/7176462 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10125
GET https://conductscience.org/api/papers/v1/10125/cited_by?page=2